A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth
Tekijät: Olotu, Opeyemi; Koskenniemi, Anna-Riina; Ma, Lin; Paramonov, Valeriy; Laasanen, Sini; Louramo, Elina; Bourgery, Matthieu; Lehtiniemi, Tiina; Laasanen, Samuli; Rivero-Müller, Adolfo; Löyttyniemi, Eliisa; Sahlgren, Cecilia; Westermarck, Jukka; Ventelä, Sami; Visakorpi, Tapio; Poutanen, Matti; Vainio, Paula; Mäkelä, Juho-Antti; Kotaja, Noora
Kustantaja: Cell Reports
Julkaisuvuosi: 2024
Journal: Cell Reports
Artikkelin numero: 114430
Vuosikerta: 43
Numero: 7
eISSN: 2211-1247
DOI: https://doi.org/10.1016/j.celrep.2024.114430
Verkko-osoite: https://www.cell.com/cell-reports/fulltext/S2211-1247(24)00759-9
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/457106509
Cancer cells undergo major epigenetic alterations and transcriptomic changes, including ectopic expression of tissue- and cell-type-specific genes. Here, we show that the germline-specific RNA helicase DDX4 forms germ-granule-like cytoplasmic ribonucleoprotein granules in various human tumors but not in cultured cancer cells. These cancerous DDX4 complexes contain RNA-binding proteins and splicing regulators, including many known germ granule components. The deletion of DDX4 in cancer cells induces transcriptomic changes and affects the alternative splicing landscape of a number of genes involved in cancer growth and invasiveness, leading to the compromised capability of DDX4-null cancer cells to form xenograft tumors in immunocompromised mice. Importantly, the occurrence of DDX4 granules is associated with poor survival in patients with head and neck squamous cell carcinoma and a higher histological grade of prostate cancer. Taken together, these results show that the germ-granule-resembling cancerous DDX4 granules control gene expression and promote the malignant and invasive properties of cancer cells.
Ladattava julkaisu This is an electronic reprint of the original article. |
Julkaisussa olevat rahoitustiedot:
This work was supported by the Academy of Finland, the Turku doctoral program of molecular medicine, the Sigrid Jusélius Foundation, the Novo Nordisk Foundation, the Jane and Aatos Erkko Foundation, and the Jalmari and Rauha Ahokas Foundation.